Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 8
1980 32
1981 92
1982 123
1983 194
1984 245
1985 257
1986 302
1987 295
1988 289
1989 343
1990 281
1991 274
1992 274
1993 281
1994 287
1995 261
1996 257
1997 223
1998 262
1999 231
2000 186
2001 203
2002 173
2003 141
2004 118
2005 142
2006 151
2007 141
2008 108
2009 103
2010 112
2011 109
2012 120
2013 105
2014 125
2015 92
2016 105
2017 93
2018 95
2019 95
2020 109
2021 128
2022 90
2023 79
2024 64
2025 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,523 results

Results by year

Filters applied: . Clear all
Page 1
Ranitidine.
Strum WB. Strum WB. JAMA. 1983 Oct 14;250(14):1894-6. JAMA. 1983. PMID: 6312110 Clinical Trial.
Ranitidine is an H2-receptor antagonist that was released recently for use in the treatment of acute duodenal ulcer disease, Zollinger-Ellison syndrome, and systemic mastocytosis with gastric hypersecretion. The pharmacokinetics, efficacy, adverse effects, and clinical uti …
Ranitidine is an H2-receptor antagonist that was released recently for use in the treatment of acute duodenal ulcer disease, Zollinge …
Ranitidine hydrochloride.
Gaginella TS, Bauman JH. Gaginella TS, et al. Drug Intell Clin Pharm. 1983 Dec;17(12):873-85. doi: 10.1177/106002808301701201. Drug Intell Clin Pharm. 1983. PMID: 6317325 Review.
Ranitidine is four to ten times more potent than cimetidine on a molar basis in inhibiting stimulated gastric acid secretion. Clinical studies have demonstrated that ranitidine is as effective as cimetidine and is similarly well tolerated. Based on available literat …
Ranitidine is four to ten times more potent than cimetidine on a molar basis in inhibiting stimulated gastric acid secretion. Clinica …
Helicobacter pylori.
Meyer JM, Hopkins RJ. Meyer JM, et al. N Engl J Med. 2003 Jan 23;348(4):363-5. doi: 10.1056/NEJM200301233480420. N Engl J Med. 2003. PMID: 12540657 No abstract available.
Ranitidine in short supply: why now, and where next?
Ryan ME, Barker C, Hawcutt DB. Ryan ME, et al. Arch Dis Child. 2020 Apr;105(4):382-383. doi: 10.1136/archdischild-2019-318447. Epub 2019 Dec 17. Arch Dis Child. 2020. PMID: 31848148 No abstract available.
Ranitidine bismuth citrate.
Chiba N, Hunt RH, Thomson AB. Chiba N, et al. Can J Gastroenterol. 2001 Jun;15(6):389-98. doi: 10.1155/2001/925106. Can J Gastroenterol. 2001. PMID: 11429668 Review.
To avoid complications of H pylori infection, such as the development of recurrent duodenal and gastric ulcers, effective therapies are required for eradication of the infection. This article reviews ranitidine bismuth citrate (RBC), a novel complex of ranitidine, b …
To avoid complications of H pylori infection, such as the development of recurrent duodenal and gastric ulcers, effective therapies are requ …
Medicine and Media: The Ranitidine Debate.
Wagner JA, Colombo JM. Wagner JA, et al. Clin Transl Sci. 2020 Jul;13(4):649-651. doi: 10.1111/cts.12753. Epub 2020 Feb 27. Clin Transl Sci. 2020. PMID: 32107850 Free PMC article.
Ranitidine has been the topic of recent media reports. Current findings, confirmed by the US Food and Drug Administration, indicate that some ranitidine products contain a substance that may be carcinogenic. ...This article comments on what is currently known about …
Ranitidine has been the topic of recent media reports. Current findings, confirmed by the US Food and Drug Administration, indicate t …
Interactions and non-interactions with ranitidine.
Kirch W, Hoensch H, Janisch HD. Kirch W, et al. Clin Pharmacokinet. 1984 Nov-Dec;9(6):493-510. doi: 10.2165/00003088-198409060-00002. Clin Pharmacokinet. 1984. PMID: 6096071 Review.
Conversely, ranitidine distinctly reduced protein-bound cobalamin absorption from a mean of 7.66% prior to ranitidine administration to 0.84% during treatment with ranitidine 300 mg daily. A significant pharmacokinetic interaction has also been demonstrated b …
Conversely, ranitidine distinctly reduced protein-bound cobalamin absorption from a mean of 7.66% prior to ranitidine administ …
Clinical pharmacokinetics of ranitidine.
Roberts CJ. Roberts CJ. Clin Pharmacokinet. 1984 May-Jun;9(3):211-21. doi: 10.2165/00003088-198409030-00003. Clin Pharmacokinet. 1984. PMID: 6329583 Review.
Ranitidine penetrates very poorly into the cerebrospinal fluid but is concentrated into breast milk. ...Food has no effect on the kinetics of ranitidine but concurrent administration of antacids reduces its absorption. Renal disease causes an increase in ranitidi …
Ranitidine penetrates very poorly into the cerebrospinal fluid but is concentrated into breast milk. ...Food has no effect on the kin …
Ranitidine-associated hallucinations.
Price W, Coli L, Brandstetter RD, Gotz VP. Price W, et al. Eur J Clin Pharmacol. 1985;29(3):375-6. doi: 10.1007/BF00544097. Eur J Clin Pharmacol. 1985. PMID: 4076334
Adverse reactions involving the central nervous system have been rarely reported with ranitidine, a H2-receptor antagonist. A 72 year old female is described that developed visual hallucinations shortly after initiation of ranitidine therapy. ...
Adverse reactions involving the central nervous system have been rarely reported with ranitidine, a H2-receptor antagonist. A 72 year …
7,523 results